Seeking Alpha

Proactive Investor's  Instablog

Proactive Investor
Send Message
Proactiveinvestors is a leading multimedia news organization, investor portal and events management business with offices in New York, Sydney, Toronto and London. Proactiveinvestors operates five financial websites in four languages providing breaking news, comment and analysis on hundreds of... More
My company:
Proactiveinvestors
My blog:
Proactiveinvestors
  • Columbia swings to third quarter profit as revenues climb by 80% 0 comments
    Nov 4, 2010 11:42 AM | about stocks: CBRX

    Columbia Laboratories (Nasdaq: CBRX) swung to a profit in the third quarter as revenues soared by nearly 80%.

    During the period, the company reported net income of $0.3 million, up from a net loss of $5.9 million in the same period last year.

    Columbia said that this year's third quarter results are not typical of past quarters, due to the sale of the company's progesterone-related assets to Watson Pharmaceuticals, and the concurrent elimination of its debt in July.

    The progesterone assets include Crinone/Prochieve, which is currently used as an infertile treatment, and is now undergoing testing for other indications such as the prevention of preterm birth.

    Total net revenues for the company increased 79% to $14.2 million, driven primarily by $8.5 million in revenue related to the gain on the sale of the progesterone assets to Watson.

    "Closing the Watson Transactions in early July greatly improved Columbia's future profit outlook," said president and CEO Frank C. Condella, Jr.

    "Our focus now is the completion of the Pregnant Study. We eagerly anticipate reporting top-line results of this pivotal Phase III clinical trial next month. Strong positive data could trigger a $6 or $8 million milestone payment from Watson and pave the way for us to file an NDA in the first half of 2011," concluded Condella.

    The company expects to report study results from the pregnant study in December.

    At quarter-end, cash and equivalents stood at $22.4 million.

    Disclosure: no position
    Themes: pharma, biotech, drug development, labs, r d Stocks: CBRX
Back To Proactive Investor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.